Peptide library › Immune & inflammation
Nangibotide
Also known as LR12
Experimental drip for septic shock that aims to calm an overactive immune response; it missed its main trial goal.
What people use it for
- Septic shock (in trials)
What Nangibotide does in the body
A short peptide that blocks TREM-1, a receptor that amplifies inflammation during severe infection.
Strength of evidence
Limited: the Phase 2b ASTONISH trial didn't meet its main goal, though some patient groups looked better.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Generally similar to placebo in trials
Who should avoid it or take extra care
- Not available outside research
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
Investigational. Not approved by the FDA.
How it's taken
Route: Drip into a vein (in trials)
How long it lasts (half-life): Short: minutes
Keep track of Nangibotide privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Nangibotide in Fiala How to installMore in Immune & inflammation
- Thymosin Alpha-1Thymus-derived immune-modulating peptide approved in several countries.
- LL-37The only human cathelicidin: an antimicrobial peptide made by the immune system.
- KPVAnti-inflammatory tripeptide taken from the end of alpha-MSH.
- VIPNeuropeptide that relaxes blood vessels and calms immune responses.
- ARA-290Peptide derived from erythropoietin (EPO), studied for nerve pain and inflammation without raising red blood cells.
- CyclosporineRing-shaped peptide from a fungus that suppresses the immune system; used after transplants and for psoriasis, arthritis and dry eye.
- ThymulinNatural thymus hormone sold online for immune support and hair growth; no modern human trials.
- EcallantideInjection that stops attacks of hereditary angioedema, a rare condition causing sudden severe swelling.
- IcatibantSelf-injected treatment for sudden swelling attacks in hereditary angioedema.
- ZilucoplanDaily self-injected peptide for generalised myasthenia gravis, an autoimmune condition that causes muscle weakness.